Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - trifluoperazine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amitriptyline hydrochloride, quantity: 50 mg - tablet, film coated - excipient ingredients: sodium starch glycollate; pregelatinised maize starch; colloidal anhydrous silica; lactose monohydrate; magnesium stearate; purified talc; disodium edetate; microcrystalline cellulose; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 4000; iron oxide black - endep 50mg tablets are indicated only for the maintenance treatment of major depression. (see precautions). nocturnal enuresis where organic pathology has been excluded.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - bupivacaine hydrochloride, quantity: 5 mg/ml (equivalent: bupivacaine hydrochloride monohydrate, qty 5.28 mg/ml) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; sodium chloride; dilute hydrochloric acid - indications as at 4 april 2000: marcain solutions are indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia - epidural block for surgery, field block (minor and major nerve blocks and infiltration). analgesia - continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. - field block (minor nerve block and infiltration). the choice of 4 strengths, 0.125%, 0.25%, 0.375% and 0.5%, makes it possible to vary the degree of motor blockade.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - prochlorperazine mesilate, quantity: 12.5 mg/ml - injection, solution - excipient ingredients: water for injections; sodium metabisulfite; sodium chloride; monoethanolamine; sodium sulfite - nausea and vomiting due to various causes including migraine; vertigo due to meniere's syndrome, labyrinthitis and other causes.

Australia - English - Department of Health (Therapeutic Goods Administration)

clinect pty ltd - periciazine, quantity: 2.5 mg - tablet, uncoated - excipient ingredients: wheat starch; magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; lactose monohydrate - severe anxiety and tension states and the maintenance treatment of the psychotic patient. it is useful in controlling such symptoms as impulsiveness and aggression.

Australia - English - Department of Health (Therapeutic Goods Administration)

clinect pty ltd - periciazine, quantity: 10 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; wheat starch; magnesium stearate; colloidal anhydrous silica - severe anxiety and tension states and the maintenance treatment of the psychotic patient. it is useful in controlling such symptoms as impulsiveness and aggression.

Australia - English - Department of Health (Therapeutic Goods Administration)

clinect pty ltd - chlorpromazine hydrochloride, quantity: 25 mg/ml - injection, solution - excipient ingredients: sodium sulfite; sodium metabisulfite; sodium citrate dihydrate; water for injections; sodium chloride - 1. treatment of acute functional psychosis (eg schizophrenia, mania or psychotic depression). 2. long-term treatment of schizophrenia. 3. short-term treatment of agitation and severe depression. 4. severe behavioural disturbances, as can be found in some children with mental retardation or autism, including the treatment of self-injurious and aggressive behaviour or overactivity. use of chlorpromazine should be in conjunction with an appropriate non-pharmacological management program and long-term use should only be carried out under the supervision of a physician experienced in the management of psychotic disorders in children. 5. in the management of terminal illness to enhance the effect of analgesics and to control nausea and vomiting. 6. control of intractable hiccough.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - trihexyphenidyl (benzhexol) hydrochloride, quantity: 5 mg - tablet, uncoated - excipient ingredients: magnesium stearate; pregelatinised maize starch; calcium hydrogen phosphate dihydrate; maize starch - as an adjunct in the therapy of all forms of parkinsonism (postencephalitis, artencephalitis, arteriosclerotic and idiopathic). it is useful in the prevention or control of extrapyramidal disorders due to cns drugs such as phenothiazines.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - trihexyphenidyl (benzhexol) hydrochloride, quantity: 2 mg - tablet, uncoated - excipient ingredients: maize starch; magnesium stearate; calcium hydrogen phosphate dihydrate; pregelatinised maize starch - as an adjunct in the therapy of all forms of parkinsonism (postencephalitis, artencephalitis, arteriosclerotic and idiopathic). it is useful in the prevention or control of extrapyramidal disorders due to cns drugs such as phenothiazines.

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - tetrabenazine, quantity: 25 mg - tablet, uncoated - excipient ingredients: purified talc; iron oxide yellow; maize starch; lactose monohydrate; magnesium stearate - may be useful for the control of chorea, hemiballismus, tardive and buccolingual dyskinesias and certain dystonic syndromes.